Interstitial biomarkers such as Twist and Vimentin have been found advantageous to detection of aggressive CTC in lung [45, 47], breast [45], and recently, pancreatic cancers [42–46] in fluorescence immunohistochemical (IHC) staining and microscopy-based selection methods. This evidence concerns the gene TWIST1 and familial pancreatic carcinoma.